Hy-Vee rolls out GLP-1 wellness program, offers free enrollment to first 1,000 sign-ups
The program follows the recent launch of Medicare’s new GLP-1 Bridge program.
GLP-1
Wegovy now accessible to eligible Medicare beneficiaries living with obesity through Medicare GLP-1 Bridge
eligible Medicare patients living with obesity can access Wegovy® (semaglutide) injection and pill for a $50 monthly copay
Walmart and Sam’s Club expand support for Medicare customers
New initiative expands access to trusted information, pharmacy support, and healthcare navigation resources for Medicare beneficiaries as Medicare GLP-1 Bridge program launches.
CVS Pharmacy expands GLP‑1 support to cut costs, boost access and help patients stay on therapy
Eligible Medicare patients can access support through a new $50 monthly copay, including one-on-one pharmacist guidance and over-the-counter products to help manage common side effects.
Wegovy pill prescriptions hit a milestone
Surpasses 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated.
Stevanato Group unveils Deora, a pen injector for subcutaneous delivery in diabetes and weight management
The fixed-dose, multi-use pen injector platform features a pull-push mechanism designed to reduce use error while supporting delivery volumes up to 0.75 mL.
Buying outside the pharmacy: 45% of peptide users who source from social media have visited the ER
A new Sunlight survey of 1,000 U.S. peptide users finds that gray-market buyers visit the ER at 3x the rate of all peptide users. Three in four of these buyers have told their doctor about their peptide use, but the doctor never sees what was bought on social media.
JustAnswer launches affordable GLP-1 weight loss platform
New direct-to-consumer site provides physician-reviewed access to compounded semaglutide and tirzepatide, delivered to patients’ doors.
Walmart expands weight management support for GLP‑1 users
Better Care Services platform connects customers to virtual care and nutrition support, complementing fast, convenient access to medications through Walmart’s nationwide pharmacy network.
RO offering Eli Lilly's Foundayo
Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary.
Ro launches Eli Lilly's KwikPen giving patients a more convenient way to take Zepbound
The most effective GLP-1 medication is now available in a multi-dose pen.
FDA approves Novo Nordisk's new Wegovy HD injection
This approval for Wegovy further expands its already robust label inclusive of multiple formulations, including Wegovy pill, and indications not available with other GLP-1 weight loss medicines.
GoodRx to expand employer-sponsored access to Zepbound KwikPen
GoodRx Employer Direct enables self-insured employers to subsidize the $449 Lilly Employer Connect medication price for Zepbound KwikPen to reduce employee out-of-pocket costs.
ShopRite unveils GLP-1 Wellness Your Way Starter Kits
Customers filling their first GLP1 prescription at a ShopRite Pharmacy will receive a complimentary kit while supplies last.
Hims & Hers launches Compounded Semaglutide Pill for weight loss
As part of a 5‑month plan, introductory pricing begins at $49 for the first month.
Vida Health partners with RxSaveCard to reduce rising GLP-1 costs
Vida’s Self-Pay (Powered by RxSaveCard) leverages a flexible proprietary payment platform to expand affordable access to obesity treatment.